M

Moderna

Develops mRNA-based medicines for health

Executive Director - Global Regulatory Strategy, Oncology

Regulatory & Quality (Life Sciences)Updated on Nov 9
Full-time

About the Job

Requirements

  • A bachelor's degree in a scientific, medical, pharmaceutical, or related discipline is required; an advanced degree (MS, PharmD, PhD, MD, or equivalent) is preferred.
  • At least 15 years of progressive Regulatory Affairs experience in the pharmaceutical or biotechnology industry, including significant experience leading global regulatory strategies for oncology programs.
  • Extensive experience in oncology drug development, particularly early clinical development, with a demonstrated track record of advancing programs toward late-stage development, registration, and approval.
  • Proven experience serving as a Global Regulatory Lead for complex development programs, including leading cross-functional regulatory strategy and contributing to major regulatory submissions and product approvals.
  • Demonstrated experience leading, mentoring, and developing regulatory professionals.
  • Deep knowledge of global regulatory requirements and pathways for oncology drug development, particularly in the United States and European Union, including expedited development and approval programs.
  • Demonstrated ability to develop innovative, science-driven regulatory strategies that optimize clinical development plans, accelerate development timelines, and establish efficient pathways to registration.
  • Extensive experience leading Health Authority interactions and negotiations, including securing alignment on clinical development plans, pivotal trial designs, and regulatory requirements.
  • Strong understanding of regulatory submission requirements, including investigational applications, CTD/eCTD formats, and major marketing applications (BLAs, NDAs, MAAs).
  • Ability to critically evaluate complex scientific and clinical data, regulatory precedents, and emerging regulatory trends to inform strategic decisions.
  • Proven ability to partner with program teams and executive leadership to challenge conventional approaches, evaluate innovative development scenarios, and influence critical program decisions.
  • Strong strategic thinking, judgment, and problem-solving skills, with the ability to navigate ambiguity, anticipate regulatory challenges, and balance scientific, regulatory, and business considerations.
  • Demonstrated ability to lead through influence, build cross-functional alignment, and drive decisions in a complex global organization.
  • Strong communication and negotiation skills, including the ability to articulate regulatory strategies and recommendations to senior executives, Health Authorities, and external stakeholders.
  • A proactive, collaborative leadership style and commitment to developing talent, fostering innovation, and advancing medicines for patients.

Responsibilities

  • Serve as the senior Global Regulatory Lead for select strategically important oncology programs, defining and driving integrated global regulatory strategies that enable progression toward late-stage development and registration.
  • Establish strategic regulatory direction across assigned oncology programs, ensuring strategies are scientifically sound, forward-looking, globally aligned, and consistent with development and business objectives.
  • Partner with program teams and executive leadership to identify and advance science-driven regulatory approaches that accelerate development timelines, optimize clinical development plans, and establish pathways toward registration.
  • Shape early development plans, including clinical development strategies, evidence-generation requirements, regulatory milestones, and considerations needed to transition into pivotal development.
  • Anticipate and navigate regulatory challenges associated with innovative therapeutic modalities, including mRNA-based therapies.
  • Monitor global regulatory expectations and identify opportunities to leverage innovative regulatory pathways, expedited development programs, regulatory precedents, and emerging regulatory science approaches to accelerate development and approval.
  • Advise program teams and senior leadership on complex regulatory challenges, strategic options, risks, and trade-offs to inform program and investment decisions.
  • Lead global Health Authority engagement strategies, including interactions with the FDA, EMA, and other regulatory agencies, to align on development plans, evidence requirements, and registration pathways.
  • Represent Moderna in Health Authority meetings and negotiations, articulating scientific and regulatory positions and advocating for innovative development approaches.
  • Lead regulatory positions and negotiation strategies and drive resolution of complex regulatory issues with Health Authorities.
  • Provide strategic oversight of regulatory submissions and interactions, including investigational applications, briefing packages, regulatory correspondence, and other filings, ensuring quality, scientific rigor, and alignment with global strategies.
  • Identify and lead resolution of regulatory issues that could affect development timelines, clinical trial design, progression into pivotal studies, or registration opportunities.
  • Serve as a core member of assigned program teams, partnering with Clinical Development, Research, Regulatory CMC, Safety, Translational Medicine, and other functions to create integrated development strategies.
  • Partner with executive leadership and program governance bodies to evaluate development scenarios, challenge conventional approaches, and recommend options that advance programs while managing regulatory risk.
  • Represent Global Regulatory Strategy in program governance and senior leadership discussions, communicating regulatory risks and opportunities and influencing development, portfolio, and investment decisions.
  • Drive alignment across global and regional regulatory functions and external partners to coordinate strategies, Health Authority positions, and execution of program priorities.
  • Provide strategic leadership, guidance, coaching, and mentorship to regulatory professionals and support development of organizational capabilities.
  • Support development of regulatory capabilities in early development strategy, innovative regulatory pathways, and Health Authority engagement through coaching, knowledge sharing, and strategic guidance.
  • Promote regulatory excellence across oncology programs and Global Regulatory Science through regulatory intelligence, best practices, and continuous learning.
  • Monitor regulatory policies, scientific developments, and industry trends relevant to oncology and innovative therapeutic modalities, translating insights into actionable strategies.
  • Contribute to the evolution of regulatory capabilities, processes, and strategic excellence across Moderna.
  • Explore and apply Generative AI and emerging digital capabilities to enhance regulatory intelligence, synthesize scientific and regulatory information, evaluate strategic scenarios, and improve regulatory decision-making.

Desired Qualifications

  • Experience with innovative therapeutic modalities, including mRNA-based therapies, immuno-oncology, or other emerging oncology technologies.

About the Company

Moderna

Develops mRNA-based medicines for health

Moderna develops medicines built on messenger RNA (mRNA). Its products use mRNA delivered into cells to instruct them to produce specific proteins that can prevent or treat disease, with vaccines being a primary example. In practice, a dose delivers engineered mRNA into the body, cells translate it into a target protein, and the immune system responds or the protein modulates biology to combat disease. Moderna differentiates itself through its focus on building a whole mRNA medicines platform and in-house capabilities for designing, manufacturing, and scaling mRNA therapies, including rapid development and large-scale production. Its goal is to create a new category of medicines based on mRNA that can improve how diseases are discovered, developed, and treated, ultimately improving patient outcomes.

Company size
5,001-10,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2010

Recently Posted Jobs

Explore more opportunities at Moderna

See more jobs